Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., late Friday authorized a third, additional dose of the mRNA COVID-19 vaccines for people with moderately to severely compromised immune systems. This includes people who have:

  • been receiving active cancer treatment for tumors or cancers of the blood;
  • received an organ transplant and are taking medicine to suppress the immune system;
  • received a stem cell transplant within the last two years or are taking medicine to suppress the immune system;
  • moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome);
  • advanced or untreated HIV infection; and
  • are undergoing active treatment with high-dose corticosteroids or other drugs that may suppress your immune response.

CDC Tuesday, Aug. 17, at 2 p.m. ET will hold a call for clinicians to discuss additional doses, along with the current data on COVID-19 vaccines in immunocompromised people. Clinicians can follow this link to participate; a recording also will be available on the COCA Call webpage a few hours after the live event ends.

Related News Articles

Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for…
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for…
Moderna Friday submitted its request that the Food and Drug Administration authorize for emergency use its bivalent COVID-19 vaccine for children and…
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current…
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will…
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal…